INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 63 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $114,970 | -9.3% | 3,636 | +17.0% | 0.00% | 0.0% |
Q2 2023 | $126,745 | +58578.2% | 3,108 | -46.3% | 0.00% | -42.9% |
Q1 2023 | $216 | +87.8% | 5,793 | +75.5% | 0.01% | +40.0% |
Q4 2022 | $115 | -100.0% | 3,300 | -91.0% | 0.01% | -84.8% |
Q3 2022 | $2,048,000 | +182.1% | 36,596 | +160.9% | 0.03% | +106.2% |
Q2 2022 | $726,000 | +476.2% | 14,029 | +707.7% | 0.02% | +1500.0% |
Q1 2022 | $126,000 | -78.7% | 1,737 | -65.4% | 0.00% | -90.0% |
Q4 2021 | $592,000 | +66.8% | 5,013 | +89.5% | 0.01% | +11.1% |
Q3 2021 | $355,000 | -21.6% | 2,645 | -5.4% | 0.01% | -25.0% |
Q2 2021 | $453,000 | -88.0% | 2,796 | -94.1% | 0.01% | -81.2% |
Q1 2021 | $3,786,000 | +11731.2% | 47,178 | +8034.1% | 0.06% | +6300.0% |
Q4 2020 | $32,000 | -73.3% | 580 | -90.5% | 0.00% | 0.0% |
Q3 2020 | $120,000 | +57.9% | 6,074 | +68.4% | 0.00% | -66.7% |
Q2 2020 | $76,000 | – | 3,606 | +23940.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 15 | -99.0% | 0.00% | -100.0% |
Q3 2019 | $19,000 | -87.2% | 1,444 | -84.1% | 0.00% | -90.0% |
Q2 2019 | $149,000 | +7350.0% | 9,078 | +7465.0% | 0.01% | – |
Q1 2019 | $2,000 | -97.1% | 120 | -95.1% | 0.00% | -100.0% |
Q3 2018 | $70,000 | +75.0% | 2,449 | +30.3% | 0.01% | +66.7% |
Q1 2018 | $40,000 | -42.9% | 1,879 | -33.0% | 0.00% | -50.0% |
Q3 2017 | $70,000 | – | 2,806 | – | 0.01% | – |
Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2016 | $27,000 | -60.9% | 2,046 | -49.3% | 0.00% | -57.1% |
Q3 2016 | $69,000 | +392.9% | 4,032 | +529.0% | 0.01% | +600.0% |
Q2 2016 | $14,000 | – | 641 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |